Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 5.102
Filter
1.
Br J Hosp Med (Lond) ; 85(5): 1-5, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38815968

ABSTRACT

An elderly male with type 2 diabetes presented with a 2-month history of otalgia and severe headaches. He was diagnosed with malignant otitis externa (MOE) and was commenced on empirical treatment with oral ciprofloxacin. Pseudomonas is the most common cause of MOE. A baseline CT scan was undertaken that demonstrated skull base osteomyelitis (SBO) due to findings of bone erosion at the mastoid tip and an infiltrating soft tissue mass eroding the clivus. Eight weeks later, he returned with worsening and bilateral symptoms of otitis externa, hearing loss, temporomandibular pain and dysfunction. Worsening and now bilateral malignant otitis externa were confirmed with an MRI scan that also demonstrated a small fluid collection in his left temporal region. The collection was aspirated and grew scedosporium apiospermum. He was diagnosed with fungal SBO and was commenced on treatment with the antifungal voriconazole, with significant improvement in symptoms and radiological findings. Fungal osteomyelitis is more likely in immunosuppressed patients, particularly those with type 2 diabetes. Fungal aetiology should be suspected in patients with progressive symptoms, despite treatment. A microbiology diagnosis of fungal SBO or MOE can be challenging to obtain and can lead to diagnostic delay. A sampling of the external auditory canal can aid in diagnosing MOE; however, scedosporium may also be isolated as a commensal organism. Aspirations from accessible fluid collections, infratemporal fossa needle sample and bone biopsy can provide material for diagnosis. Scedosporium is a rare cause of disease in humans, however, fungal infections are increasing in humans, due to an increase in susceptible populations. Scedosporium apiospermum is a rare cause of SBO and should be considered in patients not responding to standard treatment.


Subject(s)
Antifungal Agents , Osteomyelitis , Otitis Externa , Scedosporium , Skull Base , Humans , Otitis Externa/microbiology , Otitis Externa/diagnosis , Osteomyelitis/microbiology , Osteomyelitis/diagnosis , Male , Skull Base/microbiology , Antifungal Agents/therapeutic use , Scedosporium/isolation & purification , Diabetes Mellitus, Type 2/complications , Tomography, X-Ray Computed , Voriconazole/therapeutic use , Aged , Magnetic Resonance Imaging , Mycoses/diagnosis , Mycoses/complications
2.
J Craniofac Surg ; 35(4): e389-e391, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38710063

ABSTRACT

Extranodal natural killer/T-cell lymphoma is a distinct subtype of non-Hodgkin lymphoma that originates from natural killer cells or cytotoxic T cells. Its diagnosis is challenging due to the rarity and lack of awareness, especially in cases where osteomyelitis of the jawbone is the initial symptom. This paper reports a case of extranodal natural killer/T-cell lymphoma presenting primarily with oral ulcers. Through analyzing the clinical and pathological characteristics, differential diagnosis, treatment and prognosis, and reasons for misdiagnosis of the disease, this study aims to provide references for clinical diagnosis and treatment.


Subject(s)
Maxillary Sinus Neoplasms , Osteomyelitis , Humans , Osteomyelitis/diagnosis , Osteomyelitis/diagnostic imaging , Diagnosis, Differential , Maxillary Sinus Neoplasms/pathology , Maxillary Sinus Neoplasms/diagnosis , Male , Lymphoma, Extranodal NK-T-Cell/pathology , Lymphoma, Extranodal NK-T-Cell/diagnosis , Tomography, X-Ray Computed , Mandibular Diseases/diagnostic imaging , Mandibular Diseases/diagnosis , Mandibular Diseases/pathology , Oral Ulcer/diagnosis , Oral Ulcer/pathology , Middle Aged
3.
BMJ Case Rep ; 17(5)2024 May 31.
Article in English | MEDLINE | ID: mdl-38821566

ABSTRACT

This case highlights a rare presentation of diverticulitis of the sigmoid colon with perforation into the retroperitoneum complicated by abscess, vertebral osteomyelitis and acute lower extremity ischemia. A late 40-year-old man presented to an emergency department with acute ischemia of his left lower extremity. He was tachycardic with a leucocytosis, an unremarkable abdominal exam and a pulseless, insensate and paralysed left lower extremity. Imaging revealed sigmoid thickening, an abscess adjacent to iliac vasculature and occlusion of the left popliteal artery. The abscess came in contact with prior spine anterior lumbar interbody fusion (ALIF) hardware at L5-S1 vertebrae. The patient was taken urgently to the operating room for embolectomy, thrombectomy and fasciotomy. He was started on antibiotics and later underwent operative drainage with debridement for osteomyelitis. Non-operative management of the complicated diverticulitis failed, necessitating open sigmoidectomy with colostomy. 1 year later, he was symptom-free and the colostomy was reversed.


Subject(s)
Ischemia , Humans , Male , Adult , Ischemia/etiology , Ischemia/diagnosis , Retroperitoneal Space , Osteomyelitis/complications , Osteomyelitis/diagnosis , Diverticulitis, Colonic/complications , Diverticulitis, Colonic/surgery , Lower Extremity/blood supply , Anti-Bacterial Agents/therapeutic use , Abdominal Abscess/surgery , Abdominal Abscess/etiology , Embolectomy/methods , Colostomy , Abscess/complications , Abscess/therapy , Abscess/diagnosis
4.
Article in English | MEDLINE | ID: mdl-38758691

ABSTRACT

Charcot's neuroarthropathy and osteomyelitis can have similar initial presentations. The ability to differentiate between the two pathologic conditions is essential, as each requires different treatment. We present a case of a 53-year-old woman with pain, swelling, and warmth in her left first metatarsophalangeal joint and first tarsometatarsal joint. Radiographs showed comminuted fractures at the base of the first metatarsal. Osteomyelitis was suspected by the primary team based on physical findings and a history of previous first metatarsophalangeal joint arthrodesis. A triphasic bone scan and an indium white blood cell scan were positive for osteomyelitis. The podiatric medical team was suspicious for possible Charcot's neuroarthropathy based on physical findings and uncontrolled blood glucose levels at the time of her previous arthrodesis. A sulfur colloid scan was performed and compared with an indium scan, which showed no evidence of osteomyelitis. This case demonstrates the usefulness of sulfur colloid imaging compared with an indium white blood cell scan to differentiate osteomyelitis from Charcot's neuroarthropathy. This case also highlights the importance of using clinical judgment to make the correct diagnosis.


Subject(s)
Arthropathy, Neurogenic , Osteomyelitis , Humans , Osteomyelitis/diagnostic imaging , Osteomyelitis/diagnosis , Female , Middle Aged , Arthropathy, Neurogenic/diagnostic imaging , Arthropathy, Neurogenic/diagnosis , Diagnosis, Differential , Radionuclide Imaging , Technetium Tc 99m Sulfur Colloid
6.
BMJ Case Rep ; 17(5)2024 May 10.
Article in English | MEDLINE | ID: mdl-38729657

ABSTRACT

Cat-scratch disease is a zoonosis caused by Bartonella henselae, characterised by regional lymphadenopathy. Rarer presentations, such as osteomyelitis, can occur.We present an adolescent girl with severe right lumbar pain and fever, without animal contacts or recent travels. On examination, pain on flexion of torso, movement limitation and marked lordosis were noted, but there were no inflammatory signs, palpable masses or lymph nodes. Serological investigations revealed elevated inflammatory markers. Imaging revealed a paravertebral abscess with bone erosion. Several microbiological agents were ruled out. After a second CT-guided biopsy, PCR for Bartonella spp was positive. At this point, the family recalled having a young cat some time before. Cat-scratch disease was diagnosed, and complete recovery achieved after treatment with doxycycline and rifampicin.Cat-scratch disease is a challenging diagnosis in the absence of typical features. However, B. henselae must be investigated if common pathogens are ruled out and response to therapy is poor.


Subject(s)
Anti-Bacterial Agents , Bartonella henselae , Cat-Scratch Disease , Osteomyelitis , Cat-Scratch Disease/diagnosis , Cat-Scratch Disease/drug therapy , Cat-Scratch Disease/complications , Humans , Female , Osteomyelitis/microbiology , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Osteomyelitis/etiology , Bartonella henselae/isolation & purification , Anti-Bacterial Agents/therapeutic use , Adolescent , Doxycycline/therapeutic use , Rifampin/therapeutic use , Cats , Animals , Tomography, X-Ray Computed
7.
BMC Infect Dis ; 24(1): 397, 2024 Apr 12.
Article in English | MEDLINE | ID: mdl-38609851

ABSTRACT

BACKGROUND: Cryptococcal osteomyelitis is a rare and potentially serious condition, typically encountered in individuals with compromised immune systems. This case underscores the unusual occurrence of disseminated Cryptococcosis in an immunocompetent person, involving multiple bones and lungs, with Cryptococcus neoformans identified as the causative agent. CASE PRESENTATION: An Indonesian man, previously in good health, presented with a chief complaint of successive multiple bone pain lasting for more one month, without any prior history of trauma. Additionally, he reported a recent onset of fever. On physical examination, tenderness was observed in the left lateral chest wall and right iliac crest. Laboratory findings indicated mildly elevated inflammatory markers. A computed tomography (CT) scan of the chest revealed an ovoid solid nodule in the right lower lung and multifocal osteolytic lesions in the sternum, ribs, and humeral head. A magnetic resonance imaging (MRI) study of the sacrum showed multiple lesions in the bilateral iliac bone and the lower L4 vertebral body. Confirmation of Cryptococcal osteomyelitis involved a fine-needle biopsy and culture, identifying Cryptococcus neoformans in the aspirate. The patient responded positively to targeted antifungal treatments, leading to a gradual improvement in his condition. CONCLUSIONS: This case emphasizes the need to consider Cryptococcus neoformans osteomyelitis in immunocompetent patients with bone pain. A definitive diagnosis involves a fine-needle biopsy for pathology and culture, and prompt initiation of appropriate antifungal treatment has proven effective in preventing mortality.


Subject(s)
Cryptococcosis , Cryptococcus neoformans , Osteomyelitis , Male , Humans , Antifungal Agents/therapeutic use , Cryptococcosis/diagnosis , Cryptococcosis/drug therapy , Lung , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Pain
8.
Eur Rev Med Pharmacol Sci ; 28(7): 2662-2669, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38639505

ABSTRACT

OBJECTIVE: Plasma D-dimer levels >0.5 mg/L are encountered in various conditions besides venous thromboembolism (VTE). Recent studies use them as a prognostic indicator for systemic and inflammatory diseases. The clinical significance of abnormal levels is unclear in osteomyelitis patients with baseline elevation. Our study reviews the occurrence and significance of >0.5 mg/L D-dimer levels in different types of osteomyelitis. PATIENTS AND METHODS: This study involved 125 individuals, out of which 94 were male and 31 were female. The patients were divided into two groups based on the results of bacterial culture testing. Group A comprised those who tested positive for bacterial culture, while group B included those who tested negative. Out of 68 samples tested, 56% were found to have Staphylococcus aureus. All 125 patients underwent blood testing, which included measuring the D-dimer levels, neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR), and MHR monocyte to high-density lipoprotein cholesterol (HDL-C) ratio in different types of osteomyelitis. The statistical analysis of these tests was carried out. RESULTS: Although there were no significant differences in white blood cell (WBC) count, Neutrophil count, Lymphocyte count, or erythrocyte sedimentation rate (ESR) as well as the NLR, PLR, LMR, MHR, HDL-C ratio. The C-reactive protein (CRP) levels were significantly higher in group A (26.13±50.30) than in group B (10.76±18.70) (p<0.05). D-dimer levels were elevated in 40.8% of patients with bacterial culture-positive osteomyelitis, negative culture osteomyelitis, implants with fractures, and no trauma osteomyelitis. No correlation was found between the increase in D-dimer levels and the presence of bacterial culture or implant-related osteomyelitis in patients. CONCLUSIONS: No significant correlation was found between D-dimers and osteomyelitis, including positive bacterial cultures, implant-related osteomyelitis, or osteomyelitis without trauma. However, 40% of the patients had higher D-dimer levels.


Subject(s)
Fibrin Fibrinogen Degradation Products , Osteomyelitis , Humans , Male , Female , Leukocyte Count , Lymphocytes , Neutrophils , Osteomyelitis/diagnosis , Monocytes , Retrospective Studies
9.
Emerg Med Clin North Am ; 42(2): 267-285, 2024 May.
Article in English | MEDLINE | ID: mdl-38641391

ABSTRACT

Diabetic foot infection (DFI) is among the most common diabetic complications requiring hospitalization. Prompt emergency department diagnosis and evidence-based management can prevent eventual amputation and associated disability and mortality. Underlying neuropathy, arterial occlusion, immune dysfunction, and hyperglycemia-associated dehydration and ketoacidosis can all contribute to severity and conspire to make DFI diagnosis and management difficult. Serious complications include osteomyelitis, necrotizing infection, and sepsis. Practice guidelines are designed to assist frontline providers with correct diagnosis, categorization, and treatment decisions. Management generally includes a careful lower extremity examination and plain x-ray, obtaining appropriate tissue cultures, and evidence-based antibiotic selection tailored to severity.


Subject(s)
Communicable Diseases , Diabetes Mellitus , Diabetic Foot , Osteomyelitis , Humans , Diabetic Foot/diagnosis , Diabetic Foot/therapy , Communicable Diseases/complications , Osteomyelitis/diagnosis , Osteomyelitis/therapy , Osteomyelitis/complications , Anti-Bacterial Agents/therapeutic use , Diabetes Mellitus/drug therapy
10.
Ann Med ; 56(1): 2337738, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38590185

ABSTRACT

BACKGROUND: Early antimicrobial therapy is crucial regarding the prognosis of vertebral osteomyelitis, but early pathogen diagnosis remains challenging. OBJECTIVE: In this study, we aimed to differentiate the types of pathogens in iatrogenic vertebral osteomyelitis (IVO) and native vertebral osteomyelitis (NVO) to guide early antibiotic treatment. METHODS: A total of 145 patients, who had confirmed spinal infection and underwent metagenomic next-generation sequencing (mNGS) testing, were included, with 114 in the NVO group and 31 in the IVO group. Using mNGS, we detected and classified 53 pathogens in the 31 patients in the IVO group and 169 pathogens in the 114 patients in the NVO group. To further distinguish IVO from NVO, we employed machine learning algorithms to select serum biomarkers and developed a nomogram model. RESULTS: The results revealed that the proportion of the Actinobacteria phylum in the NVO group was approximately 28.40%, which was significantly higher than the 15.09% in the IVO group. Conversely, the proportion of the Firmicutes phylum (39.62%) in the IVO group was markedly increased compared to the 21.30% in the NVO group. Further genus-level classification demonstrated that Staphylococcus was the most common pathogen in the IVO group, whereas Mycobacterium was predominant in the NVO group. Through LASSO regression and random forest algorithms, we identified 5 serum biomarkers including percentage of basophils (BASO%), percentage of monocytes (Mono%), platelet volume (PCT), globulin (G), activated partial thromboplastin time (APTT) for distinguishing IVO from NVO. Based on these biomarkers, we established a nomogram model capable of accurately discriminating between the two conditions. CONCLUSION: The results of this study hold promise in providing valuable guidance to clinical practitioners for the differential diagnosis and early antimicrobial treatment of vertebral osteomyelitis.


Subject(s)
Anti-Infective Agents , Osteomyelitis , Humans , High-Throughput Nucleotide Sequencing , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Biomarkers , Iatrogenic Disease , China/epidemiology , Sensitivity and Specificity
12.
J Coll Physicians Surg Pak ; 34(4): 474-479, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38576293

ABSTRACT

OBJECTIVE: To develop an effective antimicrobial strategy for the management of chronic osteomyelitis. STUDY DESIGN: Observational study. Place and Duration of the Study: Departments of Microbiology and Orthopaedics, Combined Military Hospital Malir, Karachi, Pakistan, from January 2021 to February 2022. METHODOLOGY: Bone biopsies of 45 enrolled participants were taken for microbiological evaluation. Intravenous antibiotic therapy was begun as per empirical therapy based on the local antibiogram and antibiotic policy. Once the susceptibility pattern was available, targeted therapy started and continued for 28 to 42 days. Patients were evaluated based on inflammatory markers and clinical conditions for a minimum of six months to a maximum of one year. RESULTS:  Out of the 45 patients, the majority 29% were soldiers, 40% belonging to the age group of 31-60 years. The common predisposing factor was trauma/fractures followed by diabetes and implants leading to chronic sinus discharge and decubitus ulcers. The most commonly isolated organism was Staphylococcus aureus (38%) followed by Methicillin-resistant Staphylococcus aureus (MRSA) (31%). Cotrimoxazole and Rifampicin turned out to be good treatment options. Only 4.4% showed unsatisfactory prognosis, nonetheless, no mortality was observed during the course of treatment. CONCLUSION: In this study, highly resistant strains were observed with limited treatment options for chronic osteomyelitis, however, effective stewardship programmes with accurate diagnostic reporting and judicious use of antimicrobials can prevent overuse of the valuable resources. KEY WORDS: Antimicrobial stewardship, Osteomyelitis, Methicillin-resistant Staphylococcus aureus, Empirical therapy, Antimicrobial resistance.


Subject(s)
Antimicrobial Stewardship , Methicillin-Resistant Staphylococcus aureus , Osteomyelitis , Staphylococcal Infections , Humans , Adult , Middle Aged , Anti-Bacterial Agents/therapeutic use , Staphylococcus aureus , Staphylococcal Infections/diagnosis , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Osteomyelitis/microbiology
14.
J Pediatr (Rio J) ; 100(4): 430-437, 2024.
Article in English | MEDLINE | ID: mdl-38642591

ABSTRACT

OBJECTIVE: Signs and symptoms of osteomyelitis or septic arthritis in neonates and infants are often nonspecific and early-stage bone infections in infants may often go unnoticed. The objective of this study was to analyze the clinical characteristics of newborns and infants with osteomyelitis and septic arthritis to improve understanding of the disorder and to assist clinicians with diagnosis. METHODS: A retrospective multicenter study was conducted on neonates (0-28 days old, n = 94) and infants (1-12 months old, n = 415) with osteoarticular infections. Data consisting of clinical characteristics, complications, laboratory outcomes, and the pathogenic microorganisms causing osteomyelitis were tabulated. The statistics were further broken down into two regions and the significant differences between neonates and infants were evaluated and compared to the literature. RESULTS: Compared to infants, neonates had significantly lower incidences of fever (p < 0.0001), higher incidences of localized swelling (p = 0.0021), higher rate of infection at the humerus (p = 0.0016), higher percentage of Escherichia coli (p < 0.0001) and Klebsiella pneumoniae (p = 0.0039) infections, lower percentage of Staphylococcus aureus infections (p < 0.0001) and were more likely to develop septic arthritis (p < 0.0001). CONCLUSION: Distinct differences were found between neonatal and infants with osteoarticular infections. Future studies should focus on improving diagnosis and subsequent treatment regimens for younger age groups.


Subject(s)
Arthritis, Infectious , Osteomyelitis , Humans , Osteomyelitis/microbiology , Osteomyelitis/diagnosis , Arthritis, Infectious/microbiology , Arthritis, Infectious/diagnosis , Retrospective Studies , Infant, Newborn , Infant , Male , Female , Staphylococcal Infections
15.
Int J Infect Dis ; 144: 107027, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38670483

ABSTRACT

OBJECTIVES: The diagnostic yield and clinical impact of image-guided core needle biopsy (ICNB) of suspected vertebral osteomyelitis in adults is heterogenous in published studies owing to small sample sizes, indicating the need for large cohort studies. METHODS: A retrospective analysis of ICNBs was performed from 2010 to 2021 for patients with imaging findings consistent with vertebral osteomyelitis. For each biopsy, a series of factors were analyzed, as well as if histopathology was diagnostic of osteomyelitis and if microbiological cultures were positive. In addition, it was recorded in what way biopsy influenced clinical management regarding antimicrobial treatment. A multivariate statistical analysis was performed to evaluate the factors associated with yield. RESULTS: A total of 570 biopsies performed on 527 patients were included. A histopathologic diagnosis of osteomyelitis was made in 68.4% (359 of 525) of biopsies, and microbiological cultures were positive in 29.6% (169 of 570). Elevated erythrocyte sedimentation rate was positively associated with a histopathologic diagnosis of osteomyelitis (odds ratio [OR] =1.96, P = 0.007) and positive cultures from bone cores (OR = 1.02, P ≤0.001) and aspirate (OR = 1.02, P ≤0.001). Increased total core length was positively associated with a histopathologic diagnosis of osteomyelitis (OR = 1.81, P = 0.013) and positive cultures from bone cores (OR = 1.65, P = 0.049). Clinical management was affected by ICNB in 37.5% (214 of 570) of cases. CONCLUSIONS: In this large cohort, ICNB yielded approximately 30% positive cultures and changed clinical management in over one-third of the patients.


Subject(s)
Image-Guided Biopsy , Osteomyelitis , Humans , Osteomyelitis/diagnosis , Osteomyelitis/microbiology , Osteomyelitis/pathology , Osteomyelitis/drug therapy , Retrospective Studies , Male , Image-Guided Biopsy/methods , Female , Middle Aged , Biopsy, Large-Core Needle/methods , Aged , Adult , Aged, 80 and over , Spine/pathology , Spine/diagnostic imaging , Spine/microbiology , Spinal Diseases/diagnosis , Spinal Diseases/microbiology , Spinal Diseases/pathology , Spinal Diseases/drug therapy
16.
Br J Oral Maxillofac Surg ; 62(4): 373-377, 2024 May.
Article in English | MEDLINE | ID: mdl-38599930

ABSTRACT

This paper outlines a 10-patient case series of chronic non-bacterial osteomyelitis (CNO) of the mandible at a tertiary paediatric hospital in the UK. Our findings highlight the homogeneous presenting signs and symptoms of an intermittently painful, swollen angle and ramus of the mandible. We present the typical laboratory investigative findings (normal inflammatory markers) and imaging appearances (sclerosis and periosteal oedema). Our paper outlines an investigation protocol, including recommendations for extraoral bone biopsies and systemic magnetic resonance imaging (MRI). We explain the importance of multidisciplinary care, with combined care by rheumatologists and infectious disease specialists. Finally we demonstrate the efficacy of our treatment algorithm for oral non-steroidal anti-inflammatory drugs (NSAIDs), and in those cases refractory to NSAIDS, intravenous pamidronate. This paper provides a useful addition to the literature by informing OMF surgeons of this rare condition and given the clinical equipoise in treatments, it can hopefully guide clinicians in an investigation pathway and management protocol.


Subject(s)
Mandibular Diseases , Osteomyelitis , Humans , Osteomyelitis/diagnostic imaging , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Child , Male , Mandibular Diseases/diagnostic imaging , Mandibular Diseases/drug therapy , Female , Chronic Disease , Adolescent , Magnetic Resonance Imaging , Child, Preschool , Algorithms , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
17.
Neoreviews ; 25(5): e265-e273, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38688888

ABSTRACT

Osteomyelitis is a serious and potentially life-threatening condition affecting the skeletal system of newborns. The condition is relatively rare in neonates but occurs at higher rates in high-risk pregnancies, in preterm infants, and with the use of invasive devices. As a result of the anatomy and immature immune system of newborns, neonates differ in presentation, diagnosis, and management of osteomyelitis compared to patients of other age groups. An understanding of these differences will assist clinicians in the prompt diagnosis and management of this neonatal infection and lead to improved long-term outcomes.


Subject(s)
Osteomyelitis , Humans , Osteomyelitis/diagnosis , Osteomyelitis/therapy , Infant, Newborn
18.
J Vet Diagn Invest ; 36(2): 248-253, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38462742

ABSTRACT

Clinical and histologic examination of a 12-y-old client-owned Quarter Horse gelding with pituitary pars intermedia dysfunction revealed dermatitis, cellulitis, and osteomyelitis caused by Aspergillus nidulans, confirmed by a PCR assay. This novel presentation of a fungal disease in a horse was characterized by aggressive local invasion and failure to respond to all medical therapy attempted over a 1-y period. Treatments included systemic and topical antifungals, anti-inflammatories, and use of cellular matrices. Surgical excision was not attempted but should be strongly considered early in the disease process in similar cases if clean margins can be achieved. Postmortem findings were of locally aggressive disease with no dissemination.


Subject(s)
Aspergillus nidulans , Dermatitis , Horse Diseases , Osteomyelitis , Pituitary Diseases , Pituitary Gland, Intermediate , Horses , Male , Animals , Cellulitis/veterinary , Horse Diseases/diagnosis , Horse Diseases/pathology , Pituitary Diseases/diagnosis , Pituitary Diseases/veterinary , Pituitary Gland, Intermediate/pathology , Osteomyelitis/diagnosis , Osteomyelitis/veterinary , Dermatitis/pathology , Dermatitis/veterinary
19.
Int Wound J ; 21(3): e14770, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38484740

ABSTRACT

The objective of this paper was to investigate erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) in diagnosing pedal osteomyelitis (OM) in patients with and without diabetes, and with and without severe renal impairment (SRI). This was a retrospective cohort study of patients with moderate and severe foot infections. We evaluated three groups: Subjects without diabetes (NDM), subjects with diabetes and without severe renal insufficiency (DM-NSRI), and patients with diabetes and SRI (DM-SRI). SRI was defined as eGFR <30. We evaluated area under the curve (AUC), cutoff point, sensitivity and specificity to characterize the accuracy of ESR and CRP to diagnose OM. A total of 408 patients were included in the analysis. ROC analysis in the NDM group revealed the AUC for ESR was 0.62, with a cutoff value of 46 mm/h (sensitivity, 49.0%; specificity, 76.0%). DM-NSRI subjects showed the AUC for ESR was 0.70 with the cutoff value of 61 mm/h (sensitivity, 68.9%; specificity 61.8%). In DM-SRI, the AUC for ESR was 0.67, with a cutoff value of 119 mm/h (sensitivity, 46.4%; specificity, 82.40%). In the NDM group, the AUC for CRP was 0.55, with a cutoff value of 6.4 mg/dL (sensitivity, 31.3%; specificity, 84.0%). For DM-NSRI, the AUC for CRP was 0.70, with a cutoff value of 8 mg/dL (sensitivity, 49.2%; specificity, 80.6%). In DM-SRI, the AUC for CRP was 0.62, with a cutoff value of 7 mg/dL (sensitivity, 57.1%; specificity, 67.7%). While CRP demonstrated relatively consistent utility, ESR's diagnostic cutoff points diverged significantly. These results highlight the necessity of considering patient-specific factors when interpreting ESR results in the context of OM diagnosis.


Subject(s)
Diabetes Mellitus , Diabetic Foot , Osteomyelitis , Humans , Diabetic Foot/diagnosis , Retrospective Studies , Biomarkers , Osteomyelitis/diagnosis , C-Reactive Protein/analysis , Sensitivity and Specificity , Blood Sedimentation
SELECTION OF CITATIONS
SEARCH DETAIL
...